Horwood James, Akbar Fayaz, Davis Katherine, Morgan Richard
Department of General Surgery, Glan Clwyd Hospital, Rhyl, UK.
Ann R Coll Surg Engl. 2010 Apr;92(3):206-10. doi: 10.1308/003588410X12628812458293. Epub 2010 Mar 10.
INTRODUCTION: Common bile duct (CBD) stones can cause serious morbidity or mortality, and evidence for them should be sought in all patients with symptomatic gallstones undergoing cholecystectomy. Routine intra-operative cholangiography (IOC) involves a large commitment of time and resources, so a policy of selective cholangiography was adopted. This study prospectively evaluated the policy of selective cholangiography for patients suspected of having choledocholithiasis, and aimed to identify the factors most likely to predict the presence of CBD stones positively. PATIENTS AND METHODS: Data from 501 consecutive patients undergoing laparoscopic cholecystectomy (LC) for symptomatic gallstones, of whom 166 underwent IOC for suspected CBD stones, were prospectively collected. Suspicion of choledocholithiasis was based upon: (i) deranged liver function tests (past or present); (ii) history of jaundice (past or present) or acute pancreatitis; (iii) a dilated CBD or demonstration of CBD stones on imaging; or (iv) a combination of these factors. Patient demographics, intra-operative findings, complications and clinical outcomes were recorded. RESULTS: Sixty-four cholangiograms were positive (39%). All indications for cholangiogram yielded positive results. Current jaundice yielded the highest positive predictive value (PPV; 86%). A dilated CBD on pre-operative imaging gave a PPV of 45% for CBD calculi; a history of pancreatitis produced a 26% PPV for CBD calculi. Patients with the presence of several factors suggestive of CBD stones yielded higher numbers of positive cholangiograms. Of the 64 patients having a laparoscopic common bile duct exploration (LCBDE), four (6%) required endoscopic retrograde cholangiopancreatography (ERCP) for retained stones (94% successful surgical clearance of the common bile duct) and one (2%) for a bile leak. Of the 335 patients undergoing LC alone, three (0.9%) re-presented with a retained stone, requiring intervention. There were 12 (7%) requiring conversion to open operation. CONCLUSIONS: A selective policy for intra-operative cholangiography yields acceptably high positive results. Pre-operatively, asymptomatic bile duct stones rarely present following LC; thus, routine imaging of the biliary tree for occult calculi can safely be avoided. Therefore, a rationing approach to the use of intra-operative imaging based on the pre-operative indicators presented in this paper, successfully identifies those patients with bile duct stones requiring exploration. Laparoscopic bile duct exploration, performed by an experienced laparoscopic surgeon, is a safe and effective method of clearing the bile duct of calculi, with minimal complications, avoiding the necessity for an additional intervention and prolonged hospital stay.
引言:胆总管结石可导致严重的发病或死亡,对于所有接受胆囊切除术的有症状胆结石患者,均应寻找其存在的证据。常规术中胆管造影(IOC)需要大量的时间和资源投入,因此采用了选择性胆管造影策略。本研究前瞻性评估了对疑似胆总管结石患者的选择性胆管造影策略,旨在确定最有可能预测胆总管结石存在的因素。 患者与方法:前瞻性收集了501例因有症状胆结石接受腹腔镜胆囊切除术(LC)的连续患者的数据,其中166例因疑似胆总管结石接受了IOC。对胆总管结石的怀疑基于:(i)肝功能检查异常(既往或当前);(ii)黄疸病史(既往或当前)或急性胰腺炎;(iii)胆总管扩张或影像学显示胆总管结石;或(iv)这些因素的组合。记录患者的人口统计学资料、术中发现、并发症和临床结局。 结果:64例胆管造影结果为阳性(39%)。所有胆管造影的指征均产生了阳性结果。当前黄疸的阳性预测值(PPV)最高(86%)。术前影像学显示胆总管扩张对胆总管结石的PPV为45%;胰腺炎病史对胆总管结石的PPV为26%。存在多种提示胆总管结石因素的患者胆管造影阳性数量更多。在64例行腹腔镜胆总管探查术(LCBDE)的患者中,4例(6%)因残留结石需要行内镜逆行胰胆管造影(ERCP)(胆总管手术清除成功率为94%),1例(2%)因胆漏需要行ERCP。在仅接受LC的335例患者中,3例(0.9%)再次出现残留结石,需要干预。有12例(7%)需要转为开放手术。 结论:术中胆管造影的选择性策略产生了可接受的高阳性结果。术前,无症状胆管结石在LC后很少出现;因此,可以安全地避免对隐匿结石进行常规的胆道树成像。因此,基于本文提出的术前指标对术中成像进行合理使用的方法,成功地识别出那些需要探查的胆管结石患者。由经验丰富的腹腔镜外科医生进行的腹腔镜胆管探查术是一种安全有效的清除胆管结石的方法,并发症最少,避免了额外干预和延长住院时间的必要性。
Ann R Coll Surg Engl. 2010-4
J Gastrointest Surg. 2008-11
Surg Endosc. 2003-11
Cochrane Database Syst Rev. 2013-12-12
Cochrane Database Syst Rev. 2013-9-3
Surg Endosc. 2025-8
Abdom Radiol (NY). 2024-12-30
J Gastroenterol. 2023-9
Ann Surg Treat Res. 2019-12
J Gastrointest Surg. 2008-11
Clin Gastroenterol Hepatol. 2008-9
World J Gastroenterol. 2007-11-21
Int J Clin Pract. 2008-11
Am J Gastroenterol. 2007-8
Chirurgia (Bucur). 2006
Br J Surg. 2006-2